Browsing COVID-19 Research by Subject "Pandemics"

Now showing items 1-7 of 7

    • A cross-sectional study on the impact of the COVID-19 pandemic on psychological outcomes: Multiple indicators and multiple causes modeling 

      Aljaberi, Musheer A.; Alareqe, Naser A.; Alsalahi, Abdulsamad; Qasem, Mousa A.; Noman, Sarah; ... more authors ( Public Library of Science , 2022 , Article)
      Although the psychological impact of coronavirus disease 2019 (COVID-19) has been evaluated in the literature, further research is needed, particularly on post-traumatic stress disorder (PTSD) and psychological outcomes, ...

    • Call for emergency action to restore dietary diversity and protect global food systems in times of COVID-19 and beyond: Results from a cross-sectional study in 38 countries 

      Hoteit, Maha; Hoteit, Reem; Aljawaldeh, Ayoub; Van Royen, Kathleen; Pabian, Sara; ... more authors ( Elsevier , 2023 , Article)
      Background The COVID-19 pandemic has revealed the fragility of the global food system, sending shockwaves across countries' societies and economy. This has presented formidable challenges to sustaining a healthy and ...

    • Detection of SARS-CoV-2 RNA by direct RT-qPCR on nasopharyngeal specimens without extraction of viral RNA. 

      Hasan, Mohammad Rubayet; Mirza, Faheem; Al-Hail, Hamad; Sundararaju, Sathyavathi; Xaba, Thabisile; ... more authors ( Public Library of Science , 2020 , Article)
      To circumvent the limited availability of RNA extraction reagents, we aimed to develop a protocol for direct RT-qPCR to detect SARS-CoV-2 in nasopharyngeal swabs without RNA extraction. Nasopharyngeal specimens positive ...

    • Dysregulation of angiotensin converting enzyme 2 expression and function in comorbid disease conditions possibly contributes to coronavirus infectious disease 2019 complication severity 

      Hammoud, Safaa H.; Wehbe, Zena; Abdelhady, Samar; Kobeissy, Firas; Eid, Ali H.; ... more authors ( American Society for Pharmacology and Experimental Therapy , 2021 , Article Review)
      ACE2 has emerged as a double agent in the COVID-19 ordeal, as it is both physiologically protective and virally conducive. The identification of ACE2 in as many as 72 tissues suggests that extrapulmonary invasion and damage ...

    • Perspectives of clinical pharmacists on the provision of pharmaceutical care through telepharmacy services during COVID-19 pandemic in Qatar: A focus group 

      Alhmoud, Eman; Al Khiyami, Dania; Barazi, Raja; Saad, Mohammed; Al-Omari, Ali; ... more authors ( Public Library of Science , 2022 , Article)
      Background Coronavirus disease 2019 (COVID-19) pandemic created unprecedented pressures on healthcare systems and led to the widespread adoption of telepharmacy services, a practice that was not previously established in ...

    • Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety 

      Akhtar, S.; Benter, I.F.; Danjuma, M.I.; Doi, S.A.R.; Hasan, S.S.; ... more authors ( Taylor and Francis Ltd , 2020 , Article Review)
      The COVID-19 pandemic is caused by the severe acute-respiratory-syndrome-coronavirus-2 that uses ACE2 as its receptor. Drugs that raise serum/tissue ACE2 levels include ACE inhibitors (ACEIs) and angiotensin-II receptor ...

    • The case for chronotherapy in Covid-19-induced acute respiratory distress syndrome 

      Tamimi F.; Abusamak M.; Akkanti B.; Chen Z.; Yoo S.-H.; ... more authors ( John Wiley and Sons Inc , 2020 , Article)
      Coronavirus disease 2019 (COVID-19), the disease resulting from infection by a novel coronavirus, SARS-Cov2, has rapidly spread since November 2019 leading to a global pandemic. SARS-Cov2 has infected over four million ...